By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Actavis 

Morris Corporate Center III
400 Interpace Parkway
Parippany  New Jersey  07054  U.S.A.
Phone: 1-862-261-7000 Fax: n/a


SEARCH JOBS

Actavis, Inc. (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company has global and U.S. headquarters in Parsippany, New Jersey, USA, and international headquarters in Zug, Switzerland.

Actavis is the world’s third-largest generics prescription drug manufacturer, with more than 750 products marketed globally through operations in more than 60 countries. Actavis’ global branded pharmaceutical business develops and markets products principally in Urology and Women’s Health, and is committed to developing and marketing biosimilars products in Women’s Health, Oncology and other therapeutic categories. In addition, Actavis is the fourth-largest U.S. generic pharmaceutical product distributor through its Anda, Inc. business, and also develops and out-licenses generic pharmaceutical products outside of the U.S. through its Medis third-party business.

"Twice As" Video

"Our Winning Way" Video


Key Statistics


Email: actavis@actavis.com
Ownership: Public

Web Site: Actavis
Employees:
Symbol: ACT
 



Industry
Pharmaceutical






Company News
Allergan (AGN) Considers Breaking Up Into Two Businesses Months After Actavis (ACT) Merger 7/27/2015 5:47:15 AM
EXCLUSIVE: New Report Says Biosimilars Will Earn $55B by 2020, As Pfizer (PFE), Actavis (ACT), AbbVie (ABBV) Claim U.S. Market 7/7/2015 1:18:12 PM
Actavis (ACT) Eliminates 300 Jobs in Iceland 6/30/2015 7:01:12 AM
Actavis (ACT) Officially Changes Name to Allergan (AGN) 6/15/2015 6:21:57 AM
Orexigen (OREX) And Takeda (TKPYY) File Lawsuit Against Actavis (ACT) For Infringement Of Contrave Patents 6/5/2015 6:40:52 AM
Actavis (ACT) Snags FDA Approval Of NATRELLE INSPIRA Round Gel-Filled Textured Breast Implants 6/5/2015 6:22:21 AM
Actavis (ACT) To Present At The Goldman, Sachs & Co. 36th Annual Global Healthcare Conference 6/4/2015 7:23:38 AM
Actavis (ACT) Affirms Commitment To Advancing Antibiotic Stewardship At White House Forum 6/2/2015 12:14:01 PM
Actavis (ACT) And Perrigo (PRGO) Receive FDA Approval Of Guaifenesin/Pseudoephedrine, The Store Brand Equivalent To Mucinex D Tablets 6/2/2015 6:09:49 AM
Actavis (ACT) Completes Acquisition Of Auden Mckenzie 6/1/2015 6:48:25 AM
12345678910...
//-->